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Predictive, structure-based model of amino acid recognition by
nonribosomal peptide synthetase adenylation domains
Gregory L Challis, Jacques Ravel and Craig A Townsend
Background: Nonribosomal peptide synthetases (NRPSs) are large modular
proteins that selectively bind, activate and condense amino acids in an ordered
manner. Substrate recognition and activation occurs by reaction with ATP
within the adenylation (A) domain of each module. Recently, the crystal
structure of the A domain from the gramicidin synthetase (GrsA) with
L-phenylalanine and adenosine monophosphate bound has been determined.
Results: Critical residues in all known NRPS A domains have been identified
that align with eight binding-pocket residues in the GrsA A domain and define
sets of remarkably conserved recognition templates. Phylogenetic relationships
among these sets and the likely specificity determinants for polar and nonpolar
amino acids were determined in light of extensive published biochemical data for
these enzymes. The binding specificity of greater than 80% of the known NRPS
A domains has been correlated with more than 30 amino acid substrates. 
Conclusions: The analysis presented allows the specificity of A domains of
unknown function (e.g. from polymerase chain reaction amplification or genome
sequencing) to be predicted. Furthermore, it provides a rational framework for
altering of A domain specificity by site-directed mutagenesis, which has
significant potential for engineering the biosynthesis of novel natural products.
Introduction
A wide range of biologically active peptides is synthe-
sized by nonribosomal peptide synthetases (NRPSs) in
bacteria and fungi. These metabolites show functional
diversity and include antibiotics (e.g. penicillins, van-
comycin, bacitracin and gramicidin), siderophores (e.g.
mycobactin and enterobactin), toxins (e.g. syringomycin
and HC-toxin) and immunosuppressive agents (e.g.
rapamycin and cyclosporin). The biosyntheses of nonri-
bosomal peptides share a common mechanism, which has
been widely investigated (for reviews see [1–3]). Briefly,
NRPSs are large multifunctional enzymes of
100–1700 kDa [2] that have a modular structural organiza-
tion and are thought to link amino acid residues according
to the multiple-carrier thiotemplate mechanism [4–8].
The minimal module is composed of an amino-acid-acti-
vating domain, a thiolation domain and a condensation
domain. The activation domain recognizes a substrate
amino (or hydroxy) acid, usually specifically, and activates
it as its acyl adenylate by reaction with ATP. This active
ester is then covalently linked as its thioester to the
enzyme-bound 4′-phosphopantetheine located within the
module. The reaction continues by the direct transfer to
another acylamino acid intermediate on the adjacent
downstream module mediated by the condensation
domain to form a peptide bond. In some cases, modifica-
tions (epimerization, N- or C-methylation or cyclization)
are catalyzed by additional domains or by modified
domains within a module. A terminal thioesterase is fre-
quently present to release the peptide from the enzyme
by cyclization or hydrolysis.
In most NRPSs the organization and order of the modules
maps in a 1:1 manner to the amino acid sequence of the
peptide products (co-linearity rule). This paradigm has
allowed researchers to assign a specific amino acid activa-
tion function to each module. Exceptions have appeared
recently, however, that seem to violate this paradigm.
Nocardicin A is a monocyclic β-lactam antibiotic known to
be derived from nocardicin G [9]. A tripeptide composed
of L-serine and two units of 4-hydroxy-L-phenylglycine
(HPG) would seem the logical precursor of nocardicin G
[10]. We have recently determined, however, that a pair of
NRPSs is contained in the nocardicin A biosynthetic
cluster encompassing five modules rather than the
expected three (S.D. Breazeale, M. Gunsior and C.A.T.,
unpublished observations). In addition, Pseudomonas
syringae syringomycin is a cyclic lipodepsinonapeptide
whose synthetase genetic organization does not respect
the co-linearity rule [11]. The module activating the
carboxy-terminal threonine encoded by the gene syrB1 is
located upstream of syrE, which encodes the first eight
amino-acid-activating modules. Mycobacterium smegmatis
produces exochelin MS, a pentapeptide siderophore [12].
Genetic analysis has revealed the presence of six NRPS
modules rather than the expected five. The role of the
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sixth module could not be assigned [13]. The genetic
organization of the bleomycin biosynthetic cluster has
been elucidated recently and has indicated the presence
of 11 NRPS modules for eight amino acids units in the
peptide product [14].
In the past decade, enormous progress has been made in
the discovery and sequencing of NRPS genes from bacte-
ria and fungi (for a comprehensive list see [3] and
Tables S1 and S2 in the Supplementary material section).
Many of these putative peptide synthetases produce pep-
tides of unknown structure, but all share the well-con-
served characteristic signature sequences of NRPSs
summarized by Marahiel et al. [2]. 
Specificity is principally, but not exclusively, controlled at
the adenylation/ pantetheinylation step [1,15]. Conti et al.
[16] have recently identified, by crystal structure analysis,
the substrate-binding pocket of the phenylalanine adeny-
lation (A) domain of the gramicidin S synthetase (GrsA)
from Bacillus brevis. The amino acids lining the substrate-
binding pocket mediate amino acid specificity. The
authors concluded that, because of the high degree of
sequence identity among NRPS activation domains, the
GrsA structure represents a structural model that all
NRPS activation domains could fit [16]. 
Motivated by the exceptions to the co-linearity rule seen in
our laboratory and cases emerging in the literature, we have
developed a method to reveal the amino acid building
blocks activated by individual adenylation domains on the
basis of their sequence. Here we describe the protein
sequence analysis of over 150 NRPS activation domains to
pinpoint the essential amino acid residues involved in sub-
strate specificity and binding. As this manuscript was
nearing completion, a similar approach was described by
Stachelhaus et al. [17], in which phylogenetic and structure-
based analyses identified these essential residues and
allowed a correlation with substrate specificity to be estab-
lished. Although the X-ray structure of GrsA formed the
common basis for our two approaches, we have both rein-
forced, and extended the analysis to include 33 amino acid
substrates (Table S1) for which the function of adenylation
domains has been assigned by either direct enzymic assay,
or convincing deduction, and for which multiple protein
sequences are available of A domains recognizing specific
amino acids. Care has been taken to assemble an accurate
and comprehensive database to ensure the integrity of these
correlations. In many cases it is possible to suggest the
chemical basis for substrate selectivity, whereas in others,
distinct binding motifs have been identified that pose inter-
esting questions for further research to understand the
origins of their specificity at a fundamental level. We
present an algorithm at the first level for the prediction of
function of uncharacterized A domains translated from
newly isolated gene sequences, which provides at a second
level a framework for rational mutagenesis to alter the selec-
tion of amino acid for activation at a given module. Eight
amino acid residues have been identified whose order and
alignment can be readily applied to refine and advance
current phylogenetic analyses. Application of this structural
mask has made it possible for A domains of diverse evolu-
tionary origins to be correlated directly to function with far
greater accuracy than anticipated at the outset of this study. 
Results and discussion
Analysis of adenylation domains using phylogenetic tools
Phylogenetic analysis and sequence alignments have been
applied to A domains and revealed limited correlation
with function [18–23]. The small number of sequences, or
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Figure 1
(a) The substrate-binding pocket of the
gramicidin S synthase (GrsA) phenylalanine-
activating domain, viewed from above. The
eight residues thought to be important for
substrate selection are indicated (Ile299 is
obscured by Ala301). The figure was
generated from 1amu.pdb using RasMol.
(b) Identification of the eight amino acids
lining the substrate binding pocket of four
A domains from different genera:
Streptomyces calcium-dependent antibiotic
synthetase Cda1-M2 and Bacillus fengycin
synthetase FenD-M2, which both activate
L-threonine; Amycolatopsis chloroeremomycin
synthetase CepA-M3 and Bacillus bacitracin
synthetase BacC-M5, which both activate
L-asparagine. The sequence of each A domain
was aligned to the sequence of GrsA, and
critical amino acids were identified. The
secondary structural elements in the GrsA
sequence are indicated: α helices are boxed
in green and β sheets are boxed in blue.
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only a single genus, used and the choice of a large number
of residues make these analyses of limited value.
On the basis of the assumption that the eight amino acids
lining the binding pocket (Figure 1a) determine substrate
specificity, we used phylogenetic tools to establish a rela-
tionship between these important residues and substrate
specificity in 154 A domains in the database. We believe
that these residues are sufficient to both predict and, in
many cases, rationalize the substrate specificity of NRPS
A domains. 
To validate the theory, the eight residues lining the
binding pocket of the A domain were obtained from all
known sequences in the database, after aligning each to
that of the phenylalanine A domain of GrsA using the
ClustalX multiple alignment software (Figure 1b) [24].
Two phylogenetic trees were constructed, one based on
the 180–200 amino acids spanning motifs A3–A6
(Figure S1 in the Supplementary material section) as
described previously by Konz et al. [20] and the other
based on the eight critical residues (Figure S2). Tables S1
and S2 in the Supplementary material list the identity of
these residues and their position according to the number-
ing of GrsA [16]. In contrast to the analysis of Stachelhaus
et al. [17], we chose to exclude Cys331 because the
sidechain of this residue points away from the specificity
pocket in GrsA [16]. This observation does not, however,
exclude the possibility that residues in this position could
participate in substrate selection in other A domains.
Lys517 was omitted because it is strictly conserved and is
not involved in substrate discrimination.
The functional clustering observed when limiting the
analysis to the eight amino acids lining the binding
pocket (Figure S2) is far greater than that observed in the
analysis of 180–200 amino acids encompassing motif
A3–A6, which shows clustering predominantly among
genus lines (Figure S1). This is certainly because the
phylogenetic analysis of 180 amino acids is more likely to
emphasize genus-specific mutational evolution than func-
tional evolution of the protein studied. This result sup-
ports the importance of the residues lining the binding
pocket in defining the function of each binding pocket, as
observed similarly by Stachelhaus et al. [17]. A dichotomy
between eukaryotic and prokaryotic domains is still
observed, however, but to a lesser extent. 
Prokaryotic activation domains appear to be the result of
an evolutionary mechanism involving horizontal transfer.
The analysis of whole modules by sequence alignments
shows that a greater homology is observed in the regions
flanking the A domain (data not shown) [16]. Moreover,
the functional clustering (Figure S1) among prokaryotic A
domains makes it unlikely that they arose by convergent
evolution, and there is no evidence for an ancient activa-
tion domain originating by transfer from a eukaryotic
ancestor (Figures S1, S2 in the Supplementary material).
In some cases, such as the leucine A domains of GrsB and
TycC, it is possible to imagine an independent evolution-
ary mechanism. These A domains do not cluster according
to their function on either tree. A more detailed phyloge-
netic analysis would be needed to confirm such an evolu-
tionary hypothesis for this important group of enzymes.
The phylogenetic tree in Figure S2 can serve as a tool for
predicting the amino acid selectivity of activation domains
and for discerning evolutionary relationships among syn-
thetases of diverse origin. A more detailed analysis is
required, however, to identify important residues for sub-
strate recognition through, for example, hydrogen
bonding, electrostatic or Van der Waals interactions. 
Functional analysis of amino-acid-activating domains
We first generated a schematic of the specificity pocket
based on the crystal structure of the phenylalanine-activat-
ing domain of the gramacidin S synthetase GrsA (Figure 2).
Schematics of the predicted specificity pocket structures
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Figure 2
(a) Three-dimensional structure generated
from 1amu.pdb using RasMol (version 2.6)
and (b) two-dimensional representation of
the specificity pocket from the phenylalanine-
activating domain of GrsA. In all the
two-dimensional representations, residue
coding is as follows: acidic, red; basic, blue;
neutral polar, yellow; hydrophobic, gray. Hy
represents a variable hydrophobic residue; N
represents a nonconserved residue.
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for each A domain in the database were then produced by
mapping to this template the eight critical residues identi-
fied by the sequence alignments. In general, the predicted
specificity pocket structures fall into one of two groups,
depending on the chemical nature of the substrate’s
sidechain. For domains that activate amino acids with polar
sidechains, one or two universally conserved polar residues
can be identified that presumably interact with the sub-
strate sidechain through hydrogen bonding and electrosta-
tic interactions. The remaining residues in the specificity
pocket are hydrophobic and vary among domains that acti-
vate the same amino acid. In contrast, for substrates with
hydrophobic sidechains, the residues lining the specificity
pockets are all hydrophobic, except for proline and pipeco-
late. Although some of these residues appear to be highly
conserved, variation in other residues seems to be toler-
ated. This finding, coupled with the observation that many
of these domains have a lower substrate selectivity than
those that activate polar amino acids, makes it difficult to
assign functional roles for individual residues. The follow-
ing discussion is, therefore, split into two main sections on
domains that activate substrates with polar sidechains and
those that activate substrates with hydrophobic sidechains.
Substrates with polar sidechains
Serine-, threonine- and 4-hydroxyphenylglycine-activating
domains
The enterobactin synthetase EntF and the first two
modules of the syringomycin synthetase SyrE have been
cloned, overexpressed, purified and shown to specifically
activate L-serine [11,25]. Sequence alignment of these
proteins and the putative L-serine-activating domain from
the calcium-dependent antibiotic (CDA) synthetase Cda1
predicts highly conserved structures for the specificity
pockets (Figure 3a). In particular, the His278/Ser301 dyad
is universally conserved. Mapping of this dyad to the GrsA
structure suggests a functional role in serine selection,
which is hydrogen bonding of the His278 nitrogen to the
Ser301 hydroxyl group, which in turn hydrogen bonds to
the substrate hydroxyl group.
Although no domains that specifically activate 4-hydroxy-
L-phenylglycine (HPG) have been biochemically 
characterized, the predicted specificity pocket structures
for the putative HPG-activating domains from the chloro-
eremomycin synthetase CepB and the CDA synthetase
are highly conserved (Figure 3b). Furthermore, comparing
the predicted structures for the L-serine- and HPG-acti-
vating domains reveals that they have a remarkably similar
architecture. The principal difference is the substitution
of Ser301 in the former with Gly301 in the latter. From a
functional perspective, this could be explained by direct
hydrogen bonding of the HPG hydroxyl group to the
His278 nitrogen. In contrast, the analysis of Stachelhaus et
al. [17] places a leucine residue at this position. Our analy-
sis indicates that serine- and HPG-activating domains
could be functionally interconverted by the single point
mutation Ser301↔Gly301.
Functional characterization of the cloned syringomycin
synthetase SyrB has shown that it specifically activates
L-threonine [11]. Wild-type actinomycin synthetase AcmB
also activates L-threonine [26]. Sequence alignment of
these domains with the putative L-threonine-activating
domains from fengycin synthetases FenD and Pps2,
pristinamycin I synthetase SnbC, exochelin synthetase
FxbC, pyoverdin synthetase PvdD and CDA synthetase
Cda1 reveals highly conserved predicted structures for the
specificity pocket (Figure 4a). Interestingly, and unexpect-
edly, these structures are quite different from those pre-
dicted for the specificity pocket of the L-serine-activating
domains (Figure 3a). This difference presumably reflects
the need to specifically activate threonine in the presence
of serine. A comparison of the predicted structures of the
threonine-activating domains with that of the mycobactin
synthetase MbtB module 1 (Figure 4b), which ostensibly
contains a domain capable of activating both L-serine and
L-threonine, suggests how this might be achieved. In our
analysis, Asn278 is universally conserved (unlike in [17])
and probably interacts with the threonine hydroxyl. There
are, however, a number of other amino acid substitutions
(Phe236→Met, Trp239→Leu and Met322→Leu), that
presumably diminish specificity in the MbtB A domain.
It should be noted that the excluded residue 331 is histidine
in these cases. For this residue to be involved in hydrogen
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Figure 3
(a) Predicted structure for the specificity
pocket of L-serine-activating domains based
on alignment of the Cda1-M1, EntF, SyrE-M1
and SyrE-M2 sequences. (b) Predicted
specificity pocket structure for HPG-activating
domains based on alignment of the Cda1-M6,
CepB-M1 and CepB-M2 sequences. For
description of the domain nomenclature see
the legend for Table S1.
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bonding to the substrate hydroxyl, however, a conforma-
tional change in the specificity pocket would be required.
To test further our approach for assigning the specificity
of amino-acid-activating domains, the predicted specificity
pocket structures of the putative dehydrothreonine-acti-
vating domain of syringomycin synthetase SyrE [17] and
L-threonine-activating domains were compared. This
analysis indicated that the ‘dehydrothreonine’ and threo-
nine specificity pockets are identical in structure. It is sug-
gested, therefore, that the substrate for this domain is
actually L-threonine; the dehydroamino acid probably
being formed through dehydration of the peptide product
of the NRPS. Furthermore, exclusion of a dehydroamino
acid is consistent with chemical expectation that such an
enamine species would be neither stable in solution, nor
capable of propagating peptide elongation.
Cysteine-activating domains
Cloning and expression of residues 1–1491 of the yersini-
abactin synthetase Irp2 (HMPW2) have shown that it acti-
vates L-cysteine [27]. Sequence alignment of this protein
with the putative cysteine-activating domains from baci-
tracin synthetase BacA, anguibactin synthetase AngR and
pyochelin synthetases PchE and PchF predicts a highly
conserved structure for the specificity pocket (Figure 5a).
The universally conserved Asn278 is presumably involved
in substrate selection through interaction with the cysteine
thiol. A comparison of these structures with those predicted
for the threonine-activating domains (Figure 4a) reveals
that they share this residue. Aside from relatively conserva-
tive changes among the hydrophobic residues in the speci-
ficity pocket structures for these two substrates, the only
major difference is the Ser301→Gly substitution in the
threonine-activating domains. Ser301 therefore probably
plays an important role in selecting cysteine over threonine.
As hydrogen bonding between the Ser301 sidechain
hydroxyl group and the sidechain sulfur of cysteine is
unlikely to occur, it is not easy to assign a functional role for
this residue. A test of its role in substrate selectivity would
be to examine the effect of the mutation Ser301↔Gly.
A comparison of the structures for the cysteine-activating
domains discussed above with those predicted for the
L-cysteine-activating domains from the several known
ACV synthetases (e.g. PcbAB and AcvA from Nocardia lac-
tamdurans and Aspergillus nidulans, respectively) shows
that they are quite different (Figure 5b). In fact, the very
highly conserved ACV synthetase cysteine-activating
domain is closer in structure to that predicted for the
L-valine-activating domain from the same synthetases,
consistent with the isolation of L-(α-aminoadipoyl)-
L-valinyl–D-valine from large scale fermentations of
Cephalosporium acremonium [28]. These observations are in
keeping with the evolution of ACV synthetases through
gene duplication and subsequent functional divergence.
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Figure 4
(a) Predicted structure for the specificity
pocket of L-threonine-activating domains based
on alignment of SyrB, AcmB-M1, Cda1-M2,
FenD-M2, Pps2-M2, FxbC-M2 and SnbC-M1.
(b) Structure predicted for the L-threonine/
L-serine-activating domain from MbtB-M1.
Figure 5
(a) Predicted structures for the specificity
pocket for the L-cysteine-activating domain
from Irp2 and the putative L-cysteine-
activating domains from BacA-M2, AngR and
PchE and PchF. (b) Predicted specificity
pocket structures for AcvA and PchAB.
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Aspartate-, asparagine-, glutamate- and glutamine-activating
domains
Recombinant A domain from the second module of
lichenysin synthetase LicB was shown to specifically acti-
vate L-aspartate [20]. The purified trimodular surfactin
synthetase SrfAB has also been shown to activate L-aspar-
tate, consistent with the deduced role of the second
module incorporating this amino acid into surfactin [29].
Alignment of these sequences with the putative aspartate-
activating domains from bacitracin synthetase BacC,
lichenysin synthetase LchAB and CDA synthetases Cda1
and Cda2 predicts a highly conserved structure for the
specificity pocket. The three differences, which are genus
specific, are the substitutions His322→Ala, Val299→Ile
and Ile330→Val (Bacillus-derived→Streptomyces-derived;
Figure 6a). It seems unlikely that these differences are
functionally significant, although the specificity of any of
the Streptomyces-derived domains has yet to be examined
experimentally. The universally conserved Lys278 proba-
bly forms salt bridges with the carboxylate group of the
substrate sidechain. In contrast, Stachelhaus et al. [17]
have suggested a key interaction between the substrate
and His322. This residue, however, is replaced by alanine
in Streptomyces coelicolor, making the proposed importance
of this interaction unlikely. Additionally, Thr239 is con-
served and might contribute to substrate selection.
The A domain of the first module of tyrocidine synthetase
TycC has been shown to activate specifically L-asparagine
[30]. Alignment of this sequence with the putative
L-asparagine A domains from bacitracin synthetase BacC,
chloroeremomycin synthetase CepA and the CDA syn-
thetase Cda2 predicts highly conserved structures for the
asparagine specificity pockets, which are very similar to
the aspartate-activating domains. The predicted struc-
tures for both domains contain Lys278. The His/Ala322
residue in the structure of the aspartate-activating
domains is, however, replaced by a universally conserved
Glu322 residue in the asparagine-activating domain struc-
ture. Again, there are genus-specific variations in the
hydrophobic residues 239 and 299 (Figure 6b). A func-
tional role for Lys278 and Glu322 through hydrogen
bonding to the substrate amide can be envisioned. Salt-
bridge formation between the sidechain amino and car-
boxylate groups of these residues may anchor them close
to each other in the pocket. Furthermore, the presence of
both Lys278 and Glu322 renders the overall charge of the
pocket neutral in accord with the overall charge on the
substrate sidechain.
The functional significance of the Glu322 residue in the
asparagine-activating domains has been demonstrated
recently by Stachelhaus et al. [17]. It was shown that the
single point mutation His322→Glu in the aspartate-spe-
cific activating domain from surfactin synthetase SrfAB
completely altered the specificity to asparagine.
Comparison of the predicted specificity pocket structure
for the apparent L-aspartate-activating domain from the
syringomycin synthetase SyrE with those for the aspar-
tate-activating domains discussed above reveals extensive
differences. In fact, the structure is much closer to those
predicted for the putative L-glutamate-activating domains
from bacitracin synthetase BacA and surfactin synthetase
SrfAA (Figure 7a). Partially purified trimodular SrfAA has
been shown to activate not only L-glutamate, but also
L-aspartate at approximately one third the rate [29]. It
seems likely that the L-glutamate-activating domain also
accepts L-aspartate as a substrate, because the other two
modules in SrfAA are thought to incorporate L-leucine
(see below). The activation domains from SyrE-M8, BacA-
M4 and SrfAA-M1 therefore appear to have relaxed speci-
ficity that allows incorporation of glutamate or aspartate
into their peptide products, depending on either the avail-
ability of the substrates in the cell, or perhaps a down-
stream selectivity mechanism [15]. For these domains, a
conserved lysine residue occurs at position 239, as
opposed to position 278 in the aspartate-specific domains.
Additionally, Asp278 is conserved in the aspartate/gluta-
mate-activating domains and may help modulate the
relaxed specificity of these domains. As L-3-hydroxy-
L-aspartate occurs in syringomycin, it is also possible,
therefore, that this amino acid, not L-aspartate, is the sub-
strate for the activation domain in SyrE.
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Figure 6
(a) Predicted structures for the specificity
pockets of L-aspartate-activating domains
based on alignment of LicB-M2, LchAB-M2,
SrfAB-M2, BacC-M4, Cda1-M4, Cda1-M5
and Cda2-M1. (b) Structures predicted for
the L-asparagine-activating domains from
BacC-M5, TycC-M1, CepA-M3 and
Cda2-M3. Where two amino acid residues are
specified at a given position the first refers to
a Bacillus-derived domain and the second
refers to a Streptomyces-derived domain.
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Cloning and overexpression of the activation domain from
the first module of the lichenysin synthetase LicA has
shown that it specifically activates L-glutamine [20]. The
predicted structure for the specificity pocket is very similar
to those predicted for the glutamate/aspartate-activating
domains discussed above. The only significant difference
is the Lys239→Gln substitution (Figure 7b), which could
reflect requirement for a neutral functional group to ensure
selectivity for glutamine over glutamate. Of course, this
observation may not be general because the sequences of
only two closely related isoenzymes are currently available.
Sequence alignment of the apparent glutamate-activating
domains from fengycin synthetases Pps1/FenC,
Pps3/FenE and Pps4/FenA predicts a highly conserved
group of specificity pocket structures. Indeed, the first
two pairs of isoenzyme share identical template sequences
and differ from the third pair only in the substitution
Ser322→Gly (Table S1). Interestingly, an additional set of
isoenzymes (Fen1, Fen3 and Fen4), of undetermined
sequence, have been experimentally demonstrated to acti-
vate L-glutamate, L-glutamate and L-glutamine, respec-
tively [31]. Further research will be required to clarify the
inferred L-glutamine activation by Pps4/FenA. Unexpect-
edly, when these structures are compared with those pre-
dicted for L-serine- and L-HPG-activating domains a close
relationship is revealed (see above and Figure 4a). It
might be possible, therefore, to interconvert the substrate
specificity of these domains by point mutations at
Ser301↔Gly and Leu322↔Gly for serine↔glutamate,
and Leu322↔Ser for HPG↔glutamine.
The A domain from the second module of the tyrocidine
synthetase TycC has been cloned, overexpressed and
shown to specifically activate L-glutamine [30]. The struc-
ture of the specificity pocket is quite similar to those pre-
dicted for the apparent L-glutamate-activating domains
from the fengycin synthetases. Interestingly, the principal
difference is not Gly322→Ser but His278→Gln, which
presumably selects glutamine over glutamate through
head-to-head hydrogen bonding between the amide
groups of Gln278 and the substrate (Figure 8b).
Ornithine-, N-hydroxyornithine-, lysine- and N-hydroxylysine-
activating domains
The recombinant activating domain from the third
module of the gramicidin synthetase GrsB has been
shown to be specific for L-ornithine [32]. Alignment of
the sequence from GrsB with the putative L-ornithine-
activating domains from fengycin synthetases Pps1 and
FenC, tyrocidine synthetase TycC and bacitracin syn-
thetase BacB predicts a highly conserved structure for the
specificity pocket. Conservative substitutions occur in
the hydrophobic residues 301 and 330 (Figure 9a).
Among the remaining universally conserved residues,
Glu278 and Ser322 are probably involved in salt-bridge
formation and hydrogen bonding with the sidechain
amino group of the substrate.
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Figure 7
(a) Predicted specificity pocket structures for
the putative  L-glutamate activating domains
from SrfAA-M1 and BacA-M4, and the
putative L-aspartate-activating domain from
SyrE-M8; (b) Predicted specificity-pocket
structure for the L-glutamine-activating domain
from LicA-M1.
Figure 8
(a) Selectivity pocket structures predicted for
the apparent L-glutamate-activating domains
from Pps1/FenC-M1 and Pps3/FenE-M1
(R = H; X = O–), and Pps4/FenA-M2 (R = OH;
X = NH2). (b) Selectivity-pocket structure
predicted for the L-glutamine-activating domain
from TycC-M2.
cm7301.qxd  03/10/2000  11:44  Page 217
A comparison of these structures with those predicted for
the putative ornithine-activating domains from the
exochelin synthetase FxbC reveals substantial differ-
ences. In particular, the glutamate residue at position 278
in the former is shifted to position 239 in the latter
(Figure 9b). As the identity of the corresponding peptide
residues in exochelin itself is not ornithine, but 5-N-
hydroxyornithine [13], it is likely that these domains actu-
ally activate 5-N-hydroxyornithine. This interpretation
differs from that of Stachelhaus et al. [17], who assigned
this domain as an ornithine-activating domain. Indeed, it
has been shown this modified amino acid is incorporated
into the related siderophore ferrichrome from Ustilago
sphaerogena [33]. Furthermore, the loss of ferrichrome syn-
thesis upon disruption of an ornithine 5-N-hydroxylase
gene in Ustilago maydis indicates amino acid oxidation pre-
ceeds polypeptide formation [34].
The predicted structure for the specificity pocket of
exochelin synthetase FxbB domain is dissimilar to both
the ornithine and proposed 5-N-hydroxyornithine activat-
ing domains discussed above. As 5-N-acetyl-5-N-hydroxy-
ornithine is also incorporated into the ferrichrome of
U. sphaerogena, it seems likely that the domain from FxbB
activates 5-N-formyl-5-N-hydroxyornithine — the corre-
sponding amino acid in the exochelin structure from
M. smegmatis [13].
For the analogous family of substrates, lysine,
6-N-hydroxylysine and 6-N-acyl-6-N-hydroxylysine, a
similar pattern emerges for the predicted specificity-
pocket structures. Thus, the structures for the putative
lysine-activating domain from bacitracin synthetase BacB,
the putative 6-N-hydroxy- and 6-N-acyl-6-N-hydroxy-
lysine-activating domains from the mycobactin syn-
thetases MbtF and MbtE, respectively, all show
substantial differences (Table S1). It is, however, not pos-
sible to derive consensus specificity-pocket structures for
these substrates as these are the only domains of
known sequence.
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Figure 9
(a) Predicted specificity-pocket structures for
the L-ornithine-activating domains from GrsB
and the putative ornithine-activating domains
from FenC, Pps1, TycC and BacB.
(b) Predicted specificity-pocket structures for
the putative 5-N-hydroxyornithine-activating
domains from FxbC.
Figure 10
(a) Structures predicted for the L-leucine
specificity pockets from SrfAA-M3, SrfAB-M3,
LicB-M3, LicA-M3, LchAB-M3, LchAA-M3
and BacA-M3. (b) Structures predicted for
the specificity pockets from CepA-M1,
LchAA-M2, LicA-M2, SrfAA-M2 and SrfAC-
M1. (c) Structures predicted for the specificity
pockets from TycC-M6 and GrsB-M4.
(d) Structures predicted for the specificity
pockets from CssA-M2, CssA-M3, CssA-M8
and CssA-M10.
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Substrates with hydrophobic sidechains
Leucine-, isoleucine- and valine-activating domains
The surfactin synthetases SrfAA, SrfAB and SrfAC have
been partially purified and shown to activate L-leucine.
Competition experiments have indicated that the putative
leucine-activating domains of these synthetases also acti-
vate L-valine and L-isoleucine to a lesser extent [29]. Wild-
type gramicidin synthetase GrsB is also known to activate
L-leucine [35]. Sequence alignment of these domains with
other putative leucine-activating domains from eubacteria
— bacitracin synthetase BacA, chloroeremomycin syn-
thetase CepA, lichenysin synthetases LchAA, LchAB,
LicA and LicB, and tyrocidine synthetase TycC — pre-
dicts three families of highly conserved specificity pocket
structures (Figure 10a–c). In accordance with the
lipophilicity of the substrate sidechain, the residues lining
this pocket are principally hydrophobic. It is, therefore,
difficult to assign functional roles for particular residues in
these structures. A fourth family of specificity pocket
structures for leucine-activating domains is formed by the
four from the eukaryotic cyclosporin synthetase CssA
(Figure 10d). These structures, which are again composed
almost entirely of hydrophobic residues, are all identical.
Experimental characterization of the recombinant fengy-
cin synthetase FenB and purification of the isoenzyme
Fen5 have demonstrated that these enzymes both activate
L-isoleucine [31,36]. FenB was also shown to activate
L-valine with about one tenth of the efficiency. The acti-
vating domain from the third module of the lichenysin
synthetase LicC has been cloned, overexpressed, purified
and shown to activate L-isoleucine [20]. This domain simi-
larly activates L-leucine and L-valine with about one
quarter of the efficiency. Sequence alignment of the
isoleucine-activating domains from these synthetases with
the putative isoleucine-activating domains from bacitracin
synthetases BacA, BacC and lichenysin synthetase LchAC
predicts a well-conserved family of structures for the
specificity pockets. As expected, the residues lining this
pocket are largely hydrophobic (Figure 11a). 
The wild-type surfactin, fengycin and gramicidin syn-
thetases, SrfAB, Fen3 and AcmB, respectively, have been
shown to activate L-valine [29,31,35]. In addition, the
recombinant A domain from the first module of SrfAB
activates valine and isoleucine to a lesser extent [37].
Sequence alignment of these domains with the putative
valine-activating domains from fengycin synthetases
FenE and Pps3 and lichenysin synthetase LicB and
LchAB predicts well-conserved structures, broadly similar
to those for the isoleucine-activating domains discussed
above. One striking difference is the universally con-
served Phe239/Phe278 dyad in the isoleucine-activating
domains is replaced with a Phe239/Trp278 dyad in the
valine-activating domains (Figure 11b). This is in accord
with the smaller steric size of the valine sidechain than the
isoleucine sidechain and might be important in biasing the
substrate selectivity of these domains. All of these
isoleucine- and valine-activating domains are from the
Bacillus genus.
Like the Bacillus L-isoleucine- and L-valine-activating
domains discussed above, the remaining valine-activating
domains of known sequence cluster in a genus-dependent
manner (Table S1). Their predicted specificity-pocket
structures do, however, consist mostly of hydrophobic
residues as expected. It appears, therefore, that a number
of genus-specific solutions have evolved selecting for
valine from the cellular amino acid pool, although more
sequence data will be required to substantiate this conjec-
ture. One interesting exception to this generalization,
however, is the case of AVC synthetases, which cluster
across genus lines, as noted above.
Phenylalanine-, tryptophan- and tyrosine-activating domains
Wild-type GrsA, three truncated fragments of this
monomodular synthetase and recombinant tyrocidine syn-
thetase TycA have been shown to activate both L- and
D-phenylalanine [38–40]. Sequence alignment of the acti-
vation domains from these synthetases with that from the
second module of bacitracin synthetase BacC predicts a
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Figure 11
(a) Specificity pocket structures predicted for
the L-isoleucine-activating domains from
fengycin synthetase FenB-M1 and lichenysin
synthetase LicC-M3, and for the putative
L-isoleucine-activating domains from fengycin
synthetase Pps5-M1 and bacitracin
synthetases BacA-M1, BacA-M5 and
BacC-M1. (b) Specificity pocket structures
predicted for the L-valine-activating domain
from gramicidin synthetase GrsB-M2 and the
putative L-valine-activating domains from
fengycin synthetases FenE-M2 and Pps3-M2,
lichenysin synthetases LicB-M1 and LchAB-M1
and surfactin synthetase SrfAB-M1.
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structure containing only two highly conservative substitu-
tions (Figure 12a). In contrast, cloning, overexpression and
purification of the activation domain from the third
module of the tyrocidine synthetase TycB has shown it to
activate L-tryptophan, in addition to L- and D-phenylala-
nine [30]. As both this module and TycA contain an
epimerization domain, these results are in accord with the
isolation of tyrocidines containing only D-phenylalanine at
the first position of their peptide sequence, but either
D-phenylalanine or D-tryptophan at the fourth position. A
comparison of the predicted specificity pocket structures
for the A domains of these modules reveals two substitu-
tions: Ala322→Gly and Ile330→Val (Figure 12a,b). An
inspection of the GrsA crystal structure (Figures 1,3a)
indicates that the latter substitution should not alter the
substrate specificity predicted for the TycB domain. In
contrast, the former substitution would increase the
volume of the pocket enough to allow the larger aromatic
sidechain of tryptophan to bind preferentially. Recently,
Stachelhaus et al. [17] have confirmed this hypothesis by a
mutagenesis experiment (Ala322→Gly).
As tyrocidines containing either L-phenylalanine or
L-tryptophan at the third position of their peptide
sequence are also known [30], TycB-M2 might be
expected to contain an activating domain of similar archi-
tecture to TycB-M3. For reasons that are unclear,
however, a comparison of the structures predicted for the
specificity pockets of these two domains shows that they
are quite different (Figure 12b,c).
Comparing the structure for the third module of the tyro-
cidine synthetase TycB with those predicted for the puta-
tive tryptophan-activating domains from the second and
third modules of the CDA synthetases Cda1 and Cda3,
respectively, reveals that they are of similar structure. The
principal nonconservative substitution is Gly322→Ser
(Figure 12). As variants of the CDA containing L- or
D-phenylalanine in place of the L-tryptophan residues are
not known it seems that Ser322 plays a pivotal role in
selecting tryptophan over phenylalanine. This could be
achieved through hydrogen bonding between the trypto-
phan N-H and Ser322.
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Figure 12
(a) Specificity-pocket structures predicted for
the D-/L-phenylalanine-activating domains from
gramacidin synthetase GrsA and tyrocidine
synthetase TycA and the putative
D-/L-phenylalanine-activating domain from
bacitracin synthetase BacC-M2;
(b) specificity pocket structure predicted for
the D-/L-phenylalanine- and L-tryptophan-
activating domain from tyrocidine synthetase
TycB-M3; (c) specificity pocket structure
predicted for the putative L-phenylalanine-/
L-tryptophan-activating domain from tyrocidine
synthetase TycB-M2; (d) specificity-pocket
structures predicted for L-tryptophan-
activating domains from the calcium-
dependent antibiotic synthetases Cda1-M3
and Cda3-M2.
Figure 13
(a) Predicted structure for the specificity
pocket of the L-tyrosine/L-tryptophan-
activating domain from tyrocidine synthetase
TycC-M3. (b) Predicted structures for the
specificity pockets of the putative L-tyrosine-
activating domains from fengycin synthetases
FenA-M3/Pps4-M3 and FenD-M1/Pps2-M1.
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Cloning and overproduction of the activating domain from
the third module of tyrocidine synthetase TycC has
shown that it activates either L-tyrosine or L-tryptophan
with approximately the same efficiency [30]. This finding
is in accord with the structure of tyrocidine D, which con-
tains tryptophan in place of tyrosine at the seventh posi-
tion. In contrast, the purified wild-type fengycin
synthetases Fen2 and Fen4 are reported to activate L-tyro-
sine, but not L-tryptophan [31]. In line with these observa-
tions, no tryptophan-containing analogs of fengycin appear
to be known and, indeed, tyrosine at position 3 is lac-
tonized in the product. Comparison of the structures for
the specificity pocket for the A domain from Fen2 and
Fen4 isoenzymes FenD-M1/Pps2-M1 and FenA-
M3/Pps4-M3, respectively, with that from TycC-M3 indi-
cates a possible reason for these differences in substrate
selectivity. Glu322 is therefore universally conserved in
the five domains and could have a role in substrate selec-
tion by hydrogen bonding to the aromatic hydroxyl group
of tyrosine. Residue Thr239, however, which is univer-
sally conserved in the fengycin structures, is replaced by
leucine in the tyrocidine structure (Figure 13). This
residue could also be involved in tyrosine selection
through hydrogen bonding with the hydroxyl group of this
substrate. The replacement of this residue with a
hydrophobic one could therefore lead to relaxed substrate
specificity and allow tryptophan to bind as well.
A comparison of the predicted specificity-pocket structures
for the A domains from chloroeremomycin synthetases
CepA and CepB with those for the tyrosine-activating
domain, discussed above, reveals several differences. The
differences may confer specificity for 3-hydroxy-tyrosine,
which has been shown to be incorporated into the closely
related glycopeptide vancomycin [41]. 
The two aromatic rings in the myxobacterial metabolite
saframycin MX1 have been shown to derive from tyrosine
by precursor incorporation experiments [42]. Other exper-
iments with blocked mutants, however, have suggested
that the substrate for the putative tyrosine-activating
domains from saframycin synthetases SafA and SafB is
actually 3-hydroxy-4-methoxy-L-phenylalanine [43]. In
line with this suggestion, the predicted specificity-pocket
structures for these domains are quite different from the
other tyrosine-activating domains; they curiously lack
polar residues capable of hydrogen bonding with the sub-
strate (Figure 14b).
Proline- and pipecolate-activating domains
The recombinant activating domains from the first
modules of the tyrocidine and gramicidin synthetases,
TycB and GrsB [30,44], and the wild-type fengycin syn-
thetase Fen1 have been shown to activate L-proline [31].
A comparison of the predicted structure of the specificity
pocket from the former domains with those from the puta-
tive L-proline-activating domains from the Fen1 isoen-
zymes Pps4/FenA and the pristinamycin/virginiamycin
synthetases SnbDE reveals that they are highly con-
served. Given that proline is a hydrophobic amino acid, it
is at first sight surprising that a number of polar residues is
present in these predicted structures (Figure 15a).
Proline, however, has much greater solubility in water
than comparable aliphatic amino acids, which might
account for the substrate specificity conferred by these
binding pockets.
The synthetase responsible for pipecolate incorporation in
the biosynthesis of immunomycin has been purified from
Streptomyces hygroscopicus var. ascomyceticus. This enzyme
activates L-proline with about one fifth the efficiency, and
a number of proline and pipecolate derivatives as well
[45]. Consistent with these observations, disrupting of the
putative cyclodeaminase responsible for conversion of
L-lysine to L-pipecolate in S. hygroscopicus, which produces
the related immunosuppressant rapamycin, led to the syn-
thesis of prolylrapamycin as the major product [46]. A
comparison of the predicted specificity pocket structures
for the pipecolate-incorporating enzymes from the
rapamycin and FK-506 biosynthetic gene clusters reveals
that they are similar to those for the proline-activating
enzymes discussed above (Figure 15). The ability for
these enzymes to activate and incorporate L-proline is
therefore readily explained.
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Figure 14
(a) Predicted structures for the specificity
pockets of the putative 3-hydroxy-L-tyrosine-
activating domains from chloroeremomycin
synthetases CepA-M3 and CepB-M3.
(b) Predicted specificity pocket structures for
the putative 3-hydroxy-4-methoxy-
L-phenylalanine-activating domains from the
saframycin MX1 synthetases SafA-M1 and
SafB-M2.
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Other amino-acid-activating domains
For the domains that activate amino acids other than those
discussed above, either more than one domain has not
been sequenced (histidine, 3-methylglutamate, β-alanine,
arginine, phenylglycine, 3,5-dihydroxyphenylglycine and
2-butenyl-3-methyl-L-threonine), or the specificity pocket
structures deduced from the available information show
weak homology (alanine and glycine). For these cases,
more sequence data will be required to derive consensus
structures for the specificity pockets. As glycine has no
sidechain and the sidechain of alanine is very small, it may
transpire that there are many degenerate solutions to
selectively activating these substrates. 
One interesting case worthy of comment, however, is
β-alanine seen in the siderophore exochelin [13]. In the
predicted specificity pocket, the otherwise universally
conserved aspartate residue at position 235 is displaced to
position 236. This striking change presumably accommo-
dates the greater separation between the amino and car-
boxyl termini of this substrate.
Limitations
A clear shortcoming of the available biochemical data is
that it is limited mostly to A domains from E. coli, Bacillus
sp. and Pseudomonas sp. The important actinomycetes,
notably Streptomyces, are largely missing from this essential
database. Additional potential deficiencies are that the pre-
dictive value of the model is obviously dependent on accu-
rate sequence information available in the public domain,
the accuracy of which we have come to question in certain
instances. Moreover, in the existing literature the limited
number of potential substrates (amino acids and stereo-
chemistry) that have been tested for activity in some cases
against a particular A domain gives the impression, perhaps
falsely, of high substrate specificity. This is especially rele-
vant for recognition of hydrophobic amino acids in which
relaxed specificity is frequently observed. Looking ahead,
the substrate recognition patterns identified by this model
and that of Stachelhaus et al. [17] will provide guides for
more thoughtful consideration of potential substrates both
in overall structure, and absolute stereochemistry.
Although 19 of the 20 common amino acids are repre-
sented among the eight critical binding pocket residues,
arginine is notably absent from any of the >150 A domains
examined. The reasons for this are not understood. Simi-
larly, although some binding pockets lend themselves
readily to chemical interpretation of their substrate speci-
ficity, particularly those recognizing polar amino acids,
others do not; for example, cysteine or the strikingly polar
pockets selective for proline and pipecolate. More
broadly, a number of structural motifs have evolved to
bind nonpolar amino acids, and often less selectively than
their polar counterparts. This initial, quite empirical analy-
sis could lead to more rigorous consideration of the many
questions of molecular recognition raised by this model of
amino acid recognition and activation.
Significance
One application of this model is for the prediction of the
order and identity of amino acids activated by a nonribo-
somal peptide synthetase (NRPS) based on its sequence.
As many organisms appear to contain multiple NRPS
gene clusters, the ability to do this may greatly aid identi-
fication of a cluster of interest using the polymerase
chain reaction (PCR) with appropriately designed
primers. A second application is to rationally alter
subsets of the eight critical residues to change the amino
acid recognized and activated by these domains.
Although this experiment has not yet been carried out
with a full NRPS, encouragement can be taken from
existing, albeit limited, data that mutagenesis of recombi-
nant A domains to modify substrate specificities has
been achieved [17]. From the perspective of genetic engi-
neering, a useful comparison to the modular polyketide
synthases can be made. A large base of genetic experi-
ments exists here, where, in general, the swapping of
functional domains has given proteins of significantly
reduced synthetic ability [47,48]. More recent experi-
ments suggest that improved efficiency can be achieved
by swapping entire modules [49]. Clearly, both of these
strategies are available for the modification of NRPSs,
and, indeed, have been attempted [37,50–52]. The
unknown tertiary and quarternary structures of these
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Figure 15
(a) Predicted structures for the specificity
pockets of the L-proline-activating domains
from tyrocidine synthetase TycB-M1 and
gramicidin synthetase GrsB, and the putative
L-proline-activating domains from fengycin
synthetases FenA/Pps4 and
pristinamycin/virginiamycin synthetases
SnbDE; (b) the putative L-pipecolate-
activating domains from rapamycin synthetase
RapP and FK-506 synthetase FkbP.
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giant synthetases, however, make the effect of gross
mutational changes on catalytic efficiency impossible to
predict, but experience has shown them to be substan-
tially detrimental. The micro changes that may now be
possible to engineer into existing NRPSs on the basis of
the new model will not greatly affect their macromolecu-
lar structure and may, as a consequence, enable the
comparatively efficient synthesis of new peptide prod-
ucts. For the moment, however, the promise of this strat-
egy for creating of structurally altered natural products
will benefit from further protein sequence information to
refine the model discussed in this article and, ideally,
extend the analysis to unusual amino acid substrates of
choice. 
Materials and methods
Rasmol was used to view and analyze the crystal structure of the pheny-
lalanine activating domain of gramicidin A synthetase, GrsA (1amu.pdb),
to determine the binding pocket residues believed to be involved in sub-
strate selection. Multiple protein sequence alignments of candidate
adenylation domains were performed with ClustalX [24]. The eight criti-
cal amino acid residues lining the binding pockets of each A domain
were obtained after aligning each sequence to the GrsA sequence
using its secondary structure mask as illustrated in Figure 1. For phylo-
genetic analysis, peptide sequences were aligned using the ClustalX
multiple alignment software described above. The distance matrices
were calculated from these alignments using the Kimura protein dis-
tance algorithm [53], and trees were generated using the unweighted
pair group method arithmetic averages (UPGMA) [54] and the
GROWTREE program of the GCG Wisconsin package (version 9.0).
Identification of the predicted amino acid activated by a specific unknown
NRPS A module can be performed online in automated fashion at the
forthcoming website: http://raynam.chm.jhu.edu/~nrps/.
Supplementary material
Supplementary material including a list of amino acids lining the
binding pockets of A domains of assigned (Table S1) and unas-
signed (Table S2) functions, and phylogenetic analysis of residues
between the A3 and A6 core motif (Figure S1) and the eight putative
binding-pocket residues (Figure S2) is available at http://current-
biology.com/supmat/supmatin.htm.
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